Department of Cornea, M and J Institute of Ophthalmology, (Government Eye Hospital), B. J. Medical College, Ahmedabad, Gujarat, India.
Indian J Ophthalmol. 2021 Dec;69(12):3757-3758. doi: 10.4103/ijo.IJO_2515_21.
As COVID-19 vaccination is being undertaken all over the world, its side effects are materializing slowly. One such emerging side effect is acute graft rejection in corneal transplant (CT) cases post COVID-19 vaccination. We report a case of left eye (LE) repeat penetrating keratoplasty presenting with diminished vision in LE within 2 days of COVID-19 vaccination (ChAdOx1 nCoV-19 Corona Virus Vaccine Recombinant, COVISHIELD™). The patient was diagnosed with acute graft rejection post vaccination and was treated with topical and systemic immunosuppression therapy with successful outcome in terms improvement of visual acuity and corneal graft clarity. Timely presentation, diagnosis, and management may help to survive acute rejection episodes post vaccination.
随着 COVID-19 疫苗在全球范围内接种,其副作用也在慢慢显现。其中一个新出现的副作用是 COVID-19 疫苗接种后角膜移植(CT)病例中的急性移植物排斥反应。我们报告了一例左眼(LE)重复穿透性角膜移植术后 2 天内因 COVID-19 疫苗接种(ChAdOx1 nCoV-19 冠状病毒疫苗重组,COVISHIELD™)而出现视力下降的病例。该患者被诊断为接种后急性移植物排斥反应,并接受了局部和全身免疫抑制治疗,视力和角膜移植透明度均有所改善,结果成功。及时的表现、诊断和管理可能有助于在接种疫苗后存活急性排斥反应发作。